2021 ASCO Annual Meeting: Reports on Kidney, Esophageal, and Cervical Cancers

The ASCO Post Podcast

Konten disediakan oleh Harborside. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Harborside atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang dijelaskan di sini https://id.player.fm/legal.

3y ago 15:24

MP3•Beranda episode

Seri yang sudah diarsipkan ("Feed tidak aktif" status)

When? This feed was archived on June 25, 2023 07:37 (10M ago). Last successful fetch was on May 05, 2023 17:56 (12M ago)

Why? Feed tidak aktif status. Server kami tidak mendapatkan feed podcast yang valid secara terus-menerus.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

This week, we’re continuing our coverage of Plenary Presentations from the 2021 ASCO Annual Meeting, including research on adjuvant pembrolizumab for patients with renal cell carcinoma; novel treatment options for advanced esophageal squamous cell carcinoma; and adjuvant chemotherapy given after standard cisplatin-based chemoradiation for women with locally advanced cervical cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

185 episode

#Fitness #Harborside #Week In Review #Oncology #Science #Medicine